TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
-14.48%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$660M
AUM Growth
+$660M
(-18%)
Cap. Flow
-$3.58M
Cap. Flow
% of AUM
-0.54%
Top 10 Holdings %
Top 10 Hldgs %
41.58%
Holding
76
New
5
Increased
11
Reduced
36
Closed
8
Top Buys
| 1 |
Salesforce
CRM
|
$10.3M |
| 2 |
PayPal
PYPL
|
$10.1M |
| 3 |
Illumina
ILMN
|
$3.63M |
| 4 |
Mastercard
MA
|
$851K |
| 5 |
Walt Disney
DIS
|
$789K |
Top Sells
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$11.1M |
| 2 |
COL
Rockwell Collins
COL
|
$8.42M |
| 3 |
Trimble
TRMB
|
$1.95M |
| 4 |
United Parcel Service
UPS
|
$1.83M |
| 5 |
State Street
STT
|
$1.62M |
Sector Composition
| 1 | Healthcare | 45.7% |
| 2 | Technology | 11.39% |
| 3 | Industrials | 8.88% |
| 4 | Financials | 7.73% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DexCom
DXCM
$29.1B
| $34M | 5.15% |
283,504
-3,050
| -1% | -$365K |
|
|
2
Mastercard
MA
$535B
| $30.2M | 4.57% |
159,850
+4,509
| +3% | +$851K |
|
3
Analog Devices
ADI
$122B
| $28.3M | 4.29% |
329,656
+786
| +0.2% | +$67.5K |
|
4
Cognex
CGNX
$7.43B
| $28.3M | 4.29% |
731,550
-8,060
| -1% | -$312K |
|
5
Idexx Laboratories
IDXX
$51.2B
| $26.7M | 4.05% |
143,565
-100
| -0.1% | -$18.6K |
|
|
TIF
6
DELISTED
Tiffany & Co.
TIF
| $26.7M | 4.04% |
331,430
-5,710
| -2% | -$460K |
|
7
Danaher
DHR
$146B
| $25.8M | 3.9% |
249,846
+1,930
| +0.8% | +$199K |
|
8
Johnson & Johnson
JNJ
$429B
| $25M | 3.79% |
193,635
-2,415
| -1% | -$312K |
|
9
Neogen
NEOG
$1.23B
| $24.9M | 3.78% |
437,382
-1,035
| -0.2% | -$59K |
|
10
Brown-Forman Class B
BF.B
$13.8B
| $24.6M | 3.73% |
516,663
-3,211
| -0.6% | -$153K |
|
|
ABMD
11
DELISTED
Abiomed Inc
ABMD
| $24M | 3.64% |
73,851
-29
| -0% | -$9.43K |
|
12
Insulet
PODD
$24.3B
| $23.6M | 3.58% |
297,645
+65
| +0% | +$5.16K |
|
13
Honeywell
HON
$138B
| $20.5M | 3.11% |
155,334
-3,525
| -2% | -$466K |
|
|
RTN
14
DELISTED
Raytheon Company
RTN
| $20.4M | 3.09% |
133,017
-1,092
| -0.8% | -$167K |
|
15
Starbucks
SBUX
$102B
| $19.7M | 2.99% |
306,156
-6,325
| -2% | -$407K |
|
16
Biogen
BIIB
$20.5B
| $19.7M | 2.98% |
65,333
-1,350
| -2% | -$406K |
|
17
Inogen
INGN
$219M
| $19.2M | 2.91% |
154,635
+140
| +0.1% | +$17.4K |
|
18
Ross Stores
ROST
$49.5B
| $17.9M | 2.71% |
215,186
-1,843
| -0.8% | -$153K |
|
19
Novo Nordisk
NVO
$251B
| $17.6M | 2.66% |
381,300
-26,375
| -6% | -$1.22M |
|
20
Henry Schein
HSIC
$8.29B
| $15.4M | 2.33% |
196,043
-2,200
| -1% | -$173K |
|
21
Amgen
AMGN
$154B
| $14.6M | 2.21% |
74,900
-1,025
| -1% | -$200K |
|
22
Mettler-Toledo International
MTD
$26.3B
| $13.5M | 2.05% |
23,920
+345
| +1% | +$195K |
|
23
AbbVie
ABBV
$374B
| $10.3M | 1.56% |
111,850
-5,100
| -4% | -$470K |
|
|
24
Salesforce
CRM
$242B
| $10.3M | 1.56% |
+75,090
| New | +$10.3M |
|
|
25
PayPal
PYPL
$66.2B
| $10.1M | 1.53% |
+119,945
| New | +$10.1M |
|